Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / HEALTHCARE BUL
-
Total 13F shares
-
92,309
-
Share change
-
-123,467
-
Total reported value
-
$5,870,731
-
Put/Call ratio
-
70%
-
Price per share
-
$63.02
-
Number of holders
-
13
-
Value change
-
-$7,543,034
-
Number of buys
-
3
-
Number of sells
-
11
Institutional Holders of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) as of Q3 2020
As of 30 Sep 2020,
DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
92,309 shares.
The largest 10 holders included
HRT FINANCIAL LP, Traynor Capital Management, Inc., Virtu Financial LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Capital Analysts, LLC, UBS Group AG, CITADEL ADVISORS LLC, Tower Research Capital LLC (TRC), MORGAN STANLEY, and Kelly Financial Services LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.